ShareValue scores for PYFA.JK: Valuation 47, Quality 14, Growth 66, Health 14.

Pyridam Farma Tbk logo

PYFA.JK
IDX

Pyridam Farma Tbk

IDR 206.00(-11.21%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

2% to 18%
Valuation
47
Fair Value
Price vs Value
Quality
14
Weak
Business Strength
Growth
66
Moderate
Revenue & Earnings
Health
14
Stressed
Financial Stability
Momentum
6
Bearish
Price Trend

Company Details

About

PT Pyridam Farma Tbk engages in the pharmaceutical business in Australia, Indonesia, Philippines, Singapore, and India. The company operates through two segments, Pharmaceutical Products, Esthetic and Toll Manufacturing Services; and Medical Equipment segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides skin care and beauty products; medical support products; and other consumer health products in the form of syrups, tablets, and capsules; sterile and injection; and sanitizers and antiseptics. In addition, it offers antiseptic solutions, betadine antiseptic skin cleansers, Betadine Vaginal Douche, Cold defense nasal and throat sprays, feminine hygiene, Guardix SG, Mouthwash and Gargle, Salep antiseptic products. PT Pyridam Farma Tbk was founded in 1976 and is headquartered in Jakarta Selatan, Indonesia. PT Pyridam Farma Tbk operates as a subsidiary of Rejuve Global Investment Pte. Ltd.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026